What is he best known for?
The fields of study he is best known for:
Martin Michaelis mainly investigates Pharmacology, Virology, Virus, Apoptosis and Cell culture.
His Pharmacology research includes themes of Angiogenesis and Viral neuraminidase.
Virology is a component of his Influenza A virus and Influenza A virus subtype H5N1 studies.
He has included themes like Cancer cell, Molecular biology, Cancer research and Neuroblastoma in his Apoptosis study.
His Cancer research study combines topics in areas such as Vorinostat and NKG2D, Natural Cytotoxicity Triggering Receptor 1, Natural killer cell.
His Cell culture research includes elements of Nucleoside analogue, Ribavirin and Cell type.
His most cited work include:
- Covalent Linkage of Apolipoprotein E to Albumin Nanoparticles Strongly Enhances Drug Transport into the Brain (282 citations)
- The Story of Human Cytomegalovirus and Cancer: Increasing Evidence and Open Questions (222 citations)
- Preparation, characterisation and maintenance of drug efficacy of doxorubicin-loaded human serum albumin (HSA) nanoparticles (208 citations)
What are the main themes of his work throughout his whole career to date?
Cancer research, Pharmacology, Cell culture, Neuroblastoma and Virology are his primary areas of study.
His research integrates issues of Cell, Cell cycle, Apoptosis, Cisplatin and Drug resistance in his study of Cancer research.
His Pharmacology research is multidisciplinary, relying on both Abcg2, Transporter, ATP-binding cassette transporter, Cancer cell and Doxorubicin.
His research combines Molecular biology and Cell culture.
His studies examine the connections between Neuroblastoma and genetics, as well as such issues in Cancer, with regards to Drug.
His work in Virology tackles topics such as Immunology which are related to areas like Disease.
He most often published in these fields:
- Cancer research (31.06%)
- Pharmacology (28.79%)
- Cell culture (18.56%)
What were the highlights of his more recent work (between 2018-2021)?
- Cancer research (31.06%)
- Cell culture (18.56%)
- Drug (4.92%)
In recent papers he was focusing on the following fields of study:
His primary areas of study are Cancer research, Cell culture, Drug, Drug resistance and Neuroblastoma.
His studies deal with areas such as Cisplatin, Cell growth, Apoptosis, Cell cycle and Biomarker as well as Cancer research.
His biological study spans a wide range of topics, including Cytarabine, Leukemia, Tropism and Receptor.
His work carried out in the field of Drug brings together such families of science as Cancer, Efflux, Gene knockdown and Doxorubicin.
Martin Michaelis combines subjects such as Gene expression and Survivin with his study of Neuroblastoma.
His Distribution study is related to the wider topic of Pharmacology.
Between 2018 and 2021, his most popular works were:
- SARS-CoV-2 and SARS-CoV differ in their cell tropism and drug sensitivity profiles (37 citations)
- Doxorubicin-loaded human serum albumin nanoparticles overcome transporter-mediated drug resistance in drug-adapted cancer cells. (15 citations)
- Past and future trends of Cryptosporidium in vitro research. (15 citations)
In his most recent research, the most cited papers focused on:
The scientist’s investigation covers issues in Disease, Cell culture, Virus, Pharmacology and Virology.
The various areas that Martin Michaelis examines in his Cell culture study include Cancer research and Microbiology.
His research in Cancer research is mostly focused on Myeloid leukemia.
His studies in Virus integrate themes in fields like Outbreak, Peptide sequence, Antibody and Supplementary data.
His Pharmacology study combines topics from a wide range of disciplines, such as HaCaT and Ribavirin.
His study in the field of Viral entry is also linked to topics like Coronavirus.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
